Skip to main content

Published locations for Enfortumab vedotin shows promise as new option for urothelial carcinoma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Enfortumab vedotin shows promise as new option for urothelial carcinoma

User login

  • Reset your password
  • /content/enfortumab-vedotin-shows-promise-new-option-urothelial-carcinoma
  • /internalmedicinenews/article/236529/genitourinary-cancer/enfortumab-vedotin-shows-promise-new-option
  • /oncologypractice/article/236529/genitourinary-cancer/enfortumab-vedotin-shows-promise-new-option
  • /hematology-oncology/article/236529/genitourinary-cancer/enfortumab-vedotin-shows-promise-new-option
  • /internalmedicine/article/236529/genitourinary-cancer/enfortumab-vedotin-shows-promise-new-option